| CXSL2300316 | GLR1023注射液 | GLR-1023 | Injection | Biological Products(3.3) | New Drug Application | 2023-05-07 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2300145 | GLR1027注射液 | GLR-1027 | Injection | Biological Products(3.3) | New Drug Application | 2023-02-22 | | Gan & Lee Pharmaceuticals | | | view |
| CXHL2000606 | GLR2007 | GLR2007 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2020-11-28 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2020-11-27 | view |
| CXHL2000605 | GLR2007 | GLR2007 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2020-11-28 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2020-11-27 | view |
| CXSL2200110 | GZR101 | GZR-101 | Injection | Biological Products(1) | New Drug Application | 2022-03-03 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2100099 | GZR18 | GZR-18 | Injection | Biological Products(1) | New Drug Application | 2021-03-24 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2021-03-23 | view |
| CXSL2101256 | GZR18 | GZR-18 | Injection | Biological Products(1) | New Drug Application | 2021-08-12 | | Gan & Lee Pharmaceuticals | | | view |
| CXSB2300028 | GZR18 | GZR-18 | Injection | Biological Products(1) | Supplementary Application | 2023-03-31 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2101257 | GZR18 | GZR-18 | Injection | Biological Products(1) | New Drug Application | 2021-08-12 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2100100 | GZR18 | GZR-18 | Injection | Biological Products(1) | New Drug Application | 2021-03-24 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2021-03-23 | view |
| CXSB2300051 | GZR18 | GZR-18 | Injection | Biological Products(1) | Supplementary Application | 2023-05-11 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2101255 | GZR18 | GZR-18 | Injection | Biological Products(1) | New Drug Application | 2021-08-12 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2101258 | GZR18 | GZR-18 | Injection | Biological Products(1) | New Drug Application | 2021-08-12 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2200192 | GZR4 | GZR-4 | Injection | Biological Products(1) | New Drug Application | 2022-05-05 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2101457 | GZR4 | GZR-4 | Injection | Biological Products(1) | New Drug Application | 2021-12-06 | | Gan & Lee Pharmaceuticals | | | view |
| X0401022 | 双时相重组赖脯胰岛素注射液75/25 | | Injection | Biological Products | Supplementary Application | 2004-03-16 | 北京甘李生物技术有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2004-07-19 | view |
| CSL20020035 | 双时相重组赖脯胰岛素注射液75/25 | | Injection | Biological Products(2) | New Drug Application | 2002-06-03 | 北京甘李生物技术有限公司 | Gan & Lee Pharmaceuticals | Approval Completed-Pending Certificated | 2003-01-23 | view |
| CYSB2101051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-04-27 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2100018 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-11 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | In Review | 2022-01-19 | view |
| CYSB2300078 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
